CAD 0.34
(1.49%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.32 Million CAD | -34.21% |
2022 | 2.01 Million CAD | 23.57% |
2021 | 1.63 Million CAD | 143.03% |
2020 | 671.17 Thousand CAD | -19.06% |
2019 | 829.2 Thousand CAD | 1611.66% |
2018 | -54.85 Thousand CAD | 95.34% |
2017 | -1.17 Million CAD | -6441.88% |
2016 | 18.55 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 1.07 Million CAD | 17.58% |
2024 Q1 | 917.12 Thousand CAD | -30.85% |
2023 Q4 | 1.32 Million CAD | -6.33% |
2023 FY | 1.32 Million CAD | -34.21% |
2023 Q3 | 1.41 Million CAD | -13.88% |
2023 Q2 | 1.64 Million CAD | 3.65% |
2023 Q1 | 1.58 Million CAD | -21.31% |
2022 Q1 | 963.63 Thousand CAD | -40.92% |
2022 FY | 2.01 Million CAD | 23.57% |
2022 Q4 | 2.01 Million CAD | -18.22% |
2022 Q3 | 2.46 Million CAD | 23.79% |
2022 Q2 | 1.99 Million CAD | 106.62% |
2021 Q3 | 1.26 Million CAD | 354850.0% |
2021 FY | 1.63 Million CAD | 143.03% |
2021 Q2 | 356.00 CAD | 100.01% |
2021 Q1 | -3.16 Million CAD | -571.97% |
2021 Q4 | 1.63 Million CAD | 29.09% |
2020 Q2 | 1.12 Million CAD | -3.19% |
2020 FY | 671.17 Thousand CAD | -19.06% |
2020 Q1 | 1.16 Million CAD | 40.24% |
2020 Q4 | 671.17 Thousand CAD | -37.52% |
2020 Q3 | 1.07 Million CAD | -4.58% |
2019 Q2 | -722.3 Thousand CAD | -444.3% |
2019 FY | 829.2 Thousand CAD | 1611.66% |
2019 Q1 | 209.79 Thousand CAD | 482.46% |
2019 Q3 | -1.78 Million CAD | -147.01% |
2019 Q4 | 829.2 Thousand CAD | 146.48% |
2018 Q1 | 1.18 Million CAD | 200.85% |
2018 Q4 | -54.85 Thousand CAD | 93.64% |
2018 Q3 | -862.24 Thousand CAD | 0.0% |
2018 FY | -54.85 Thousand CAD | 95.34% |
2017 FY | -1.17 Million CAD | -6441.88% |
2017 Q4 | -1.17 Million CAD | 0.0% |
2016 FY | 18.55 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aurora Cannabis Inc. | -8.64 Million CAD | 115.335% |
Avant Brands Inc. | 17.93 Million CAD | 92.603% |
Cardiol Therapeutics Inc. | -34.77 Million CAD | 103.814% |
Crescita Therapeutics Inc. | -8.13 Million CAD | 116.31% |
Knight Therapeutics Inc. | 10.33 Million CAD | 87.162% |
MediPharm Labs Corp. | -15.68 Million CAD | 108.455% |
OrganiGram Holdings Inc. | -33.7 Million CAD | 103.934% |
Canopy Growth Corporation | 512.87 Million CAD | 99.741% |
Willow Biosciences Inc. | -989 Thousand CAD | 234.095% |
Auxly Cannabis Group Inc. | 142.88 Million CAD | 99.072% |